Literature DB >> 8804323

Prevalence of hypopigmented macules in a healthy population.

S L Vanderhooft1, J S Francis, R A Pagon, L T Smith, V P Sybert.   

Abstract

OBJECTIVE: Although hypopigmented macules are an important manifestation of tuberous sclerosis (TS), the probability of TS in healthy individuals who have hypopigmented macules is unknown. The purpose of this study was to establish the prevalence of hypopigmented macules among a cross section of the general white population. STUDY
DESIGN: The skin of 423 white individuals younger than 45 years of age was screened for hypopigmented macules with ambient incandescent and fluorescent light and a Wood lamp. Indirect ophthalmoscopy was performed in patients with unexplained hypopigmentation to screen for retinal manifestations of TS.
RESULTS: Twenty individuals (4.7%) had at least one hypopigmented macule. Of these, four had more than one macule. None had more than three. Two (8%) of the 25 hypopigmented macules were identified only with a Wood lamp. Indirect ophthalmoscopy was performed in 13 (65%) of these 20 individuals. None showed the retinal findings of TS.
CONCLUSIONS: The prevalence of hypopigmented macules in the general population has been underestimated. The presence of a few hypopigmented macules on the skin of an otherwise healthy individual without a family history of TS need not prompt an evaluation to rule out this disorder.

Entities:  

Mesh:

Year:  1996        PMID: 8804323     DOI: 10.1016/s0022-3476(96)70066-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference.

Authors:  Hope Northrup; Darcy A Krueger
Journal:  Pediatr Neurol       Date:  2013-10       Impact factor: 3.372

2.  Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.

Authors:  S Legoupil; D Bessis; F Picard; S Mallet; J Mazereeuw; A Phan; D Dupin-Deguine; M Kalamarides; C Chiaverini
Journal:  Orphanet J Rare Dis       Date:  2022-06-21       Impact factor: 4.303

3.  Assessment of tumors in children with tuberous sclerosis: a single centre's experience.

Authors:  Suna Emir; Şadan Hacısalihoğlu; Derya Özyörük; Filiz Ekici; Aydan Değerliyurt; Alev Güven; İlker Çetin
Journal:  Turk Pediatri Ars       Date:  2017-03-01

4.  The Adult Phenotype of Tuberous Sclerosis Complex.

Authors:  Neera Nathan; Kristina Burke; Cory Trickett; Joel Moss; Thomas N Darling
Journal:  Acta Derm Venereol       Date:  2016-02       Impact factor: 4.437

5.  Vitiligo prevalence and quality of life among adults in Europe, Japan and the USA.

Authors:  K Bibeau; A G Pandya; K Ezzedine; H Jones; J Gao; A Lindley; J E Harris
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06-14       Impact factor: 9.228

6.  Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.

Authors:  Mari Wataya-Kaneda; Mari Tanaka; Toshimitsu Hamasaki; Ichiro Katayama
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

7.  Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?

Authors:  Monika Słowińska; Sergiusz Jóźwiak; Angela Peron; Julita Borkowska; Dariusz Chmielewski; Krzysztof Sadowski; Elżbieta Jurkiewicz; Aglaia Vignoli; Francesca La Briola; Maria Paola Canevini; Katarzyna Kotulska-Jóźwiak
Journal:  Orphanet J Rare Dis       Date:  2018-01-29       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.